Navigation Links
Novel marker discovered for stem cells derived from human umbilical cord blood
Date:4/17/2014

New Rochelle, NY, April 17, 2014The development of stem cell therapies to cure a variety of diseases depends on the ability to characterize stem cell populations based on cell surface markers. Researchers from the Finnish Red Cross have discovered a new marker that is highly expressed in a type of stem cells derived from human umbilical cord blood, which they describe in an article in BioResearch Open Access, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the BioResearch Open Access website.

Heli Suila and colleagues, Finnish Red Cross Blood Service, Helsinki, Finland present evidence to show that the glycan O-GLcNAc, is present on the surface of stem cells and is part of a stem cell-specific surface signature. In the article "Extracellular O-Linked N-Acetylglucosamine Is Enriched in Stem Cells Derived from Human Umbilical Cord Blood" the authors suggest that the glycan plays a crucial role in a cell signaling pathway that regulates embryonic development.

"This work is particularly interesting as epidermal growth factor domains are found on the Notch receptors, suggesting that these novel glycans may be involved in Notch receptor signaling pathways in stem cells," says BioResearch Open Access Editor Jane Taylor, PhD, MRC Centre for Regenerative Medicine, University of Edinburgh, Scotland.


'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100 x2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Page: 1

Related biology news :

1. Researchers discover novel therapy for Crohns disease
2. New clinical trial explores novel noninvasive colon cancer screening test
3. Notre Dame researchers using novel method to combat malaria drug resistance
4. Unique adaptations to a symbiotic lifestyle reveal novel targets for aphid insecticides
5. Key proteins newly discovered form and function may provide novel cancer treatment target
6. Novel discovery by NUS scientists paves the way for more effective treatment of cancers
7. London researchers discover novel mechanism involved in key immune response
8. Mexican rock heroes trial novel green trading system
9. VTT and GE Healthcare developing novel biomarkers to predict Alzheimers disease
10. Cleveland Clinic researchers receive $5 million grant to discover novel pathways to heart disease
11. Novel nano-structures to realize hydrogens energy potential
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Novel marker discovered for stem cells derived from human umbilical cord blood
(Date:8/26/2014)... have provided the first evidence that the lack ... early signs of dementia. , Published in ... absence of the protein MK2/3 promotes structural and ... These changes were shown to have a significant ... learning and memory formation capabilities. , An absence ...
(Date:8/26/2014)... consumers, and suppliers has prompted manufacturers to set ... they emit from their smokestacks or discharge into ... environmental performance at every step in their process, ... use and recycling of their products. , This ... as life cycle engineering, which connects the engineers ...
(Date:8/26/2014)... University of Illinois engineers are bringing a ... researchers developed a new continuous glucose monitoring material ... the wavelength shift is so precise that doctors ... for automatic insulin dosing - something not ... , "There are significant limitations to current continuous ...
Breaking Biology News(10 mins):Lack of naturally occuring protein linked to dementia 2Yale journal explores advances in sustainable manufacturing 2A glucose meter of a different color provides continuous monitoring 2A glucose meter of a different color provides continuous monitoring 3
... therapies often succeed at initially eliminating the bulk ... but are eventually thwarted because they cannot eliminate ... cancer stem cells, which ultimately become the source ... by scientists at the University of Pittsburgh School ...
... New research from Colorado State University shows that the ... circadian -- or daily -- rhythms. The study, publishing ... current theory that only 10 percent to 15 percent ... scientists have long known that circadian rhythms regulate the ...
... temples and cultivated for its wood and cottony fibers, ... biologists have clung to for decades: the notion that ... continents were connected 96 million years ago. , Research ... colleagues shows that kapok---and perhaps other rainforest--trees colonized Africa ...
Cached Biology News:Cancer stem cells similar to normal stem cells can thwart anti-cancer agents 2Research finds that circadian rhythms dominate all life functions 2Research finds that circadian rhythms dominate all life functions 3The kapok connection -- Study explains rainforest similarities 2
(Date:8/26/2014)... MINNEAPOLIS and REHOVOT, Israel , ... UK medical 3D printing specialist, Replica 3DM, supports NHS hospitals ... 3D Printers   - Performing surgery ... and anesthetic times; improves patient recovery and provides an effective ... Stratasys Ltd. (Nasdaq: SSYS ), a ...
(Date:8/26/2014)... , Aug. 26, 2014 Technology ... the symbol (NUUU) has two (2) wholly- owned ... two subsidiaries harness scientifically advanced technology to provide ... NUUU,s Renuell Int,l, Inc. is launching ... skin care products that is made possible because ...
(Date:8/26/2014)... -- Trovagene, Inc. (NASDAQ:  TROV) presented data at ... to the Clinic with an oral presentation ... Tumor DNA in Urine." In this presentation Trovagene ... Monitoring (PCM) platform and results from several studies ... tumor DNA mutations from urine samples of cancer ...
(Date:8/26/2014)... 26, 2014 Albany Molecular Research Inc. (NASDAQ: ... S. Marth , President and Chief Executive Officer at ... Conference on Monday, September 8, 2014 at 8:45 a.m. ... the presentation can be accessed at AMRI,s Investor Relations ... webcast will be archived for 90 days following the ...
Breaking Biology Technology:Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 2Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 3Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 4Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 5Technology Applications International Corporation, Trading Symbol NUUU now trading on NASDAQ's Over the Counter Bulletin Board (OTC BB) 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4
... CALGARY, April 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,("Oncolytics") ... his research group at St. James,s University Hospital ... in the April 10 online issue of,Gene Therapy. ... by,Oncolytic Reovirus for the Treatment of Melanoma.", ...
... Technology (NIST), in collaboration with the National Aeronautics ... for making essential measurements on samples of single-walled ... current best practices for characterizing one of the ... generation of nanoscale materials. , The nanotubes are ...
... Inc. (Nasdaq: VION ) today announced that it ... The Nasdaq Capital Market,listing requirements, including the time frame ... announced that it had received a letter, dated,March 24, ... Company,that it does not comply with Marketplace Rule 4310(c ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma 2Carbon nanotube measurements: latest in NIST 'how-to' series 2Vion Pharmaceuticals Files Plan With Nasdaq 2Vion Pharmaceuticals Files Plan With Nasdaq 3
Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119], Rabbit serum, NON-neutralizing polyclonal antibody...
AANAT [Arylalkylamine N-acetyltransferase; EC 2.3.1.87]...
Rac1/2/3 (L129) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Sheep polyclonal to EBNA 3B ( Abpromise for all tested applications). Antigen: Full length protein....
Biology Products: